Anti-Tenascin C 抗体 [DB7] (ab86182)
Key features and details
- Mouse monoclonal [DB7] to Tenascin C
- Suitable for: ICC/IF, IHC-P, WB, IP
- Reacts with: Human
- Isotype: IgG2a
製品の概要
-
製品名
Anti-Tenascin C antibody [DB7]
Tenascin C 一次抗体 製品一覧 -
製品の詳細
Mouse monoclonal [DB7] to Tenascin C -
由来種
Mouse -
特異性
ab86182 reacts with the fibrinogen like knob domain of Tenascin C. -
アプリケーション
適用あり: ICC/IF, IHC-P, WB, IPmore details -
種交差性
交差種: Human -
免疫原
Full length native protein (purified) corresponding to Human Tenascin C. Tenascin polypeptides from spent culture supernatant of human fibroblasts isolated by affinity chromatography.
-
ポジティブ・コントロール
- WB: U-87 MG IHC-P: Human uterus tissue
-
特記事項
ab86182 is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
Preservative: 0.1% Sodium azide
Constituents: 1% BSA, PBS -
Concentration information loading...
-
精製度
Protein G purified -
一次抗体 備考
ab86182 is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells. -
ポリ/モノ
モノクローナル -
クローン名
DB7 -
アイソタイプ
IgG2a -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab86182の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC/IF |
Use at an assay dependent concentration.
|
|
IHC-P |
1/400.
|
|
WB |
1/1000. Predicted molecular weight: 241 kDa.
|
|
IP |
Use at an assay dependent concentration.
|
特記事項 |
---|
ICC/IF
Use at an assay dependent concentration. |
IHC-P
1/400. |
WB
1/1000. Predicted molecular weight: 241 kDa. |
IP
Use at an assay dependent concentration. |
ターゲット情報
-
機能
Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. -
配列類似性
Belongs to the tenascin family.
Contains 15 EGF-like domains.
Contains 1 fibrinogen C-terminal domain.
Contains 15 fibronectin type-III domains. -
細胞内局在
Secreted > extracellular space > extracellular matrix. - Information by UniProt
-
参照データベース
- Entrez Gene: 3371 Human
- Omim: 187380 Human
- SwissProt: P24821 Human
- Unigene: 143250 Human
-
別名
- 150 225 antibody
- Cytotactin antibody
- Glioma associated extracellular matrix antigen antibody
see all
画像
-
All lanes : Anti-Tenascin C antibody [DB7] (ab86182) at 1/1000 dilution
Lane 1 : U-87 MG Treated BFA (5µg/mL, 6h) cell lysate
Lane 2 : U-87 MG cell lysate
Performed under reducing conditions.
Predicted band size: 241 kDa
Exposure time: 20 secondsab86182 was shown to react with Tenascin C in western blot. Membranes were blocked in 2 % BSA in TBS-T (0.1 % Tween®) before incubation with ab86182 overnight at 4 °C at a 1 in 1000 dilution. Blots were incubated with HRP conjugated Goat anti-Mouse (H+L) secondary antibody at 1 in 5000 dilution for 1 hour at room temperature before development with Optiblot ECL reagent (ab133406) and imaging.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tenascin C antibody [DB7] (ab86182)
Immunohistochemical analysis of human uterus tissue labeling Tenascin C with ab98597 at 1/400 dilution.
Pretreated with enzymatic digestion 37°C for 10 minutes.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (8)
ab86182 は 8 報の論文で使用されています。
- Varkoly G et al. Expression Pattern of Tenascin-C, Matrilin-2, and Aggrecan in Diseases Affecting the Corneal Endothelium. J Clin Med 11:N/A (2022). PubMed: 36294311
- Módis LV et al. Extracellular matrix changes in corneal opacification vary depending on etiology. Mol Vis 27:26-36 (2021). PubMed: 33633437
- Shen C et al. Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs. Medicine (Baltimore) 98:e14045 (2019). PubMed: 30633201
- Gökçinar-Yagci B et al. Generation of human umbilical cord vein CD146+ perivascular cell origined three-dimensional vascular construct. Microvasc Res 118:101-112 (2018). IHC-P . PubMed: 29550275
- Onion D et al. Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer. Oncotarget 9:1760-1771 (2018). PubMed: 29416729
- Li Y et al. Differentiation of Human Amniotic Mesenchymal Stem Cells into Human Anterior Cruciate Ligament Fibroblast Cells by In Vitro Coculture. Biomed Res Int 2017:7360354 (2017). PubMed: 29085840
- Szalai E et al. Fibrillin-2, tenascin-C, matrilin-2, and matrilin-4 are strongly expressed in the epithelium of human granular and lattice type I corneal dystrophies. Mol Vis 18:1927-36 (2012). IHC-P ; Human . PubMed: 22876117
- Tiitta O et al. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol 141:907-13 (1992). PubMed: 1384340